Strait & Sound Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
10,197
-62
-0.6% -$13.3K 0.9% 25
2026
Q1
$2.23M Sell
10,259
-28
-0.3% -$6.21K 0.83% 27
2025
Q4
$2.35M Buy
10,287
+374
+4% +$85.2K 0.87% 24
2025
Q3
$2.3M Sell
9,913
-10
-0.1% -$2.04K 0.88% 25
2025
Q2
$1.84M Sell
9,923
-255
-3% -$47.4K 0.78% 30
2025
Q1
$2.13M Buy
10,178
+147
+1% +$28.6K 0.99% 22
2024
Q4
$1.78M Buy
10,031
+172
+2% +$31.6K 0.83% 22
2024
Q3
$1.95M Buy
9,859
+132
+1% +$24.6K 0.95% 19
2024
Q2
$1.67M Buy
9,727
+460
+5% +$76.2K 0.85% 21
2024
Q1
$1.55M Buy
9,267
+94
+1% +$16.2K 0.87% 22
2023
Q4
$1.49M Sell
9,173
-248
-3% -$36.2K 0.93% 21
2023
Q3
$1.4M Buy
9,421
+3,103
+49% +$456K 1.21% 18
2023
Q2
$851K Sell
6,318
-28
-0.4% -$4.11K 0.84% 29
2023
Q1
$1.01M Buy
6,346
+121
+2% +$18.5K 1.01% 20
2022
Q4
$951K Buy
+6,225
New +$954K 1.04% 23

Other funds holding ABBV

Strait & Sound Wealth Management's ABBV Position: Q2 2026 in Review

Strait & Sound Wealth Management reduced its AbbVie (ABBV) stake by 0.6% in Q2 2026, selling an estimated $13.3K and leaving 10,197 shares worth $2.57M. The position accounts for 0.9% of the portfolio, ranked #25.

Strait & Sound Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strait & Sound Wealth Management held 10,197 shares of AbbVie worth $2.57M as of Q2 2026.
  • Strait & Sound Wealth Management sold 62 AbbVie shares in Q2 2026, an estimated $13.3K.
  • AbbVie made up 0.9% of Strait & Sound Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Strait & Sound Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strait & Sound Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.